Gabapentin Treatment of Postural Tachycardia Syndrome (PoTS)

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

September 30, 2017

Study Completion Date

September 30, 2017

Conditions
Postural Orthostatic Tachycardia Syndrome
Interventions
DRUG

Gabapentin

"Gradually increasing doses of medication from 100 mg on day 1 to 300 mg twice a day on day 6. On day 7, the patient received a 300-mg dose from the day 7 envelope, about two hours after a light breakfast and 1 hour before data collection. The relatively low dose and gradual titration were selected to enhance compliance and reduce adverse effects, based on a rectal mechanosensitivity study."

All Listed Sponsors
lead

Medstar Health Research Institute

OTHER